Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cardlytics, Inc.CDLX · Entity 7603 | Chief Legal & Privacy Officer | June 09, 2022 | July 20, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cardlytics, Inc.
Report date June 09, 2022 · Filed July 20, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 52,130 |
Ending reported balance
After 2022-07-20 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2022-06-09 · Exercise / conversion · Acquired 7,813 · Balance 53,130 F1: Represents the underlying vested shares of common stock of the Issuer which have not been delivered. Row 2 · 2022-07-20 · Sale · Disposed 1,000 · Balance 52,130 F2: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 8, 2021. |
| Performance Stock UnitSEC Table II · derivative / convertible security | Direct | 7,812 |
Reported balance
After 2022-06-09 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-06-09 · Exercise / conversion · Disposed 7,813 · Balance 7,812 F3: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. F4: On December 9, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum growth rate in adjusted contribution was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted contribution growth target ("adjusted contribution growth tranche"). Fifty percent (50%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the underlying vested shares of common stock of the Issuer which have not been delivered.
F2: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 8, 2021.
F3: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F4: On December 9, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum growth rate in adjusted contribution was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted contribution growth target ("adjusted contribution growth tranche"). Fifty percent (50%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 20, 2022 Filed Jul 20, 2022 21:10 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 1,000 | $13.91 | $13,910.00 |
DisclosureSEC source: 0001666071-22-000095 · wf-form4_165835142515822.xml · nonDerivative · entry 2 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,130 F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 8, 2021. Read SEC document |
| June 22, 2022 Filed Jun 22, 2022 20:33 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 1,000 | $25.05 | $25,050.00 |
DisclosureSEC source: 0001666071-22-000082 · wf-form4_165592997882945.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,317 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 8, 2021. Read SEC document |
| June 09, 2022 Filed Jul 20, 2022 21:10 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionPerformance Stock Unit · Derivative | 7,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-22-000095 · wf-form4_165835142515822.xml · derivative · entry 3 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,812 Underlying: Common Stock · 7,813 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: On December 9, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum growth rate in adjusted contribution was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted contribution growth target ("adjusted contribution growth tranche"). Fifty percent (50%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer. F4 · derivative.expiration_date: On December 9, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum growth rate in adjusted contribution was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted contribution growth target ("adjusted contribution growth tranche"). Fifty percent (50%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer. Read SEC document |
| June 09, 2022 Filed Jul 20, 2022 21:10 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 7,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-22-000095 · wf-form4_165835142515822.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,130 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the underlying vested shares of common stock of the Issuer which have not been delivered. Read SEC document |
| May 25, 2022 Filed May 26, 2022 20:10 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 1,000 | $25.25 | $25,250.00 |
DisclosureSEC source: 0001666071-22-000077 · wf-form4_165359578850521.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,317 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 8, 2021. F2 · balance_after: Includes 291 shares of Common Stock acquired under the Issuer's Employee Stock Purchase Plan. Read SEC document |
| May 05, 2022 Filed May 9, 2022 20:13 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 3,400 | $34.66 | $117,844.00 |
DisclosureSEC source: 0001666071-22-000063 · wf-form4_165212715845865.xml · nonDerivative · entry 2 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,026 F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units that vested on March 24, 2022, April 1, 2022 and April 5, 2022 and performance stock units that vested on April 6, 2022. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $34.37 to $34.96, inclusive. Read SEC document |
| May 05, 2022 Filed May 9, 2022 20:13 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 3,332 | $34.16 | $113,821.12 |
DisclosureSEC source: 0001666071-22-000063 · wf-form4_165212715845865.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,426 F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units that vested on March 24, 2022, April 1, 2022 and April 5, 2022 and performance stock units that vested on April 6, 2022. F2 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $33.36 to $34.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| April 18, 2022 Filed Apr 19, 2022 20:26 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 177 | $46.77 | $8,278.29 |
DisclosureSEC source: 0001666071-22-000049 · wf-form4_165039998625008.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,758 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 8, 2021. Read SEC document |
| April 06, 2022 Filed Apr 7, 2022 23:25 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionPerformance Stock Unit · Derivative | 7,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-22-000040 · wf-form4_164937392904330.xml · derivative · entry 4 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,812 Underlying: Common Stock · 7,813 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F5 · derivative.exercise_date: On October 6, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum number of advertisers with a specified billings threshold over a trailing 12-month period was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the advertiser count target ("advertiser tranche"). Fifty percent (50%) of the shares subject to the advertiser tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU vested 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer. F5 · derivative.expiration_date: On October 6, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum number of advertisers with a specified billings threshold over a trailing 12-month period was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the advertiser count target ("advertiser tranche"). Fifty percent (50%) of the shares subject to the advertiser tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU vested 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer. Read SEC document |
| April 06, 2022 Filed Apr 7, 2022 23:25 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 7,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-22-000040 · wf-form4_164937392904330.xml · nonDerivative · entry 2 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,935 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the underlying vested shares of common stock of the Issuer which have not been delivered. Read SEC document |
| April 05, 2022 Filed Apr 7, 2022 23:25 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Units · Derivative | 1,704 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-22-000040 · wf-form4_164937392904330.xml · derivative · entry 3 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,114 Underlying: Common Stock · 1,704 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F3 · derivative.exercise_date: The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date. F3 · derivative.expiration_date: The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date. Read SEC document |
| April 05, 2022 Filed Apr 7, 2022 23:25 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 1,704 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-22-000040 · wf-form4_164937392904330.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,122 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the underlying vested shares of common stock of the Issuer which have not been delivered. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:57 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Units · Derivative | 8,468 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-22-000036 · wf-form4_164919221378186.xml · derivative · entry 2 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,935 Underlying: Common Stock · 8,468 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F3 · derivative.exercise_date: The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date. F3 · derivative.expiration_date: The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:57 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 8,468 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-22-000036 · wf-form4_164919221378186.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,418 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the underlying vested shares of common stock of the Issuer which have not been delivered. Read SEC document |
| March 24, 2022 Filed Mar 24, 2022 23:55 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GrantCommon Stock | 1,660 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-22-000032 · wf-form4_164816613206743.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,950 F1 · shares: Represents a restricted stock unit ("RSU") award. The shares underlying the RSU award vested immediately upon grant. Read SEC document |
| March 22, 2022 Filed Mar 24, 2022 23:55 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GrantRestricted Stock Unit · Derivative | 18,598 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-22-000032 · wf-form4_164816613206743.xml · derivative · entry 2 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,416 Underlying: Common Stock · 18,598 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F3 · derivative.exercise_date: 25% of the RSUs shall vest on April 1, 2023 with the remainder vesting in equal amounts quarterly thereafter, provided that the Reporting Person remains employed by the Issuer on such vesting date. F3 · derivative.expiration_date: 25% of the RSUs shall vest on April 1, 2023 with the remainder vesting in equal amounts quarterly thereafter, provided that the Reporting Person remains employed by the Issuer on such vesting date. Read SEC document |
| March 15, 2022 Filed Mar 16, 2022 20:54 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 1,000 | $42.82 | $42,820.00 |
DisclosureSEC source: 0001666071-22-000025 · wf-form4_164746406582835.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,290 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 8, 2021. Read SEC document |
| February 15, 2022 Filed Feb 15, 2022 21:02 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 1,000 | $68.46 | $68,460.00 |
DisclosureSEC source: 0001666071-22-000011 · wf-form4_164495894566990.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,290 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 8, 2021. Read SEC document |
| January 13, 2022 Filed Jan 13, 2022 21:06 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 1,000 | $67.97 | $67,970.00 |
DisclosureSEC source: 0001666071-22-000004 · wf-form4_164210797031928.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,290 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 8, 2021. Read SEC document |
| December 15, 2021 Filed Dec 16, 2021 21:25 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 1,000 | $66.26 | $66,260.00 |
DisclosureSEC source: 0001666071-21-000243 · wf-form4_163968994082388.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,290 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 8, 2021. Read SEC document |
| December 10, 2021 Filed Dec 13, 2021 21:19 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 1,475 | $69.65 | $102,733.75 |
DisclosureSEC source: 0001666071-21-000241 · wf-form4_163943034099412.xml · nonDerivative · entry 4 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,290 F3 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on December 9, 2021. F6 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $69.28 to $70.17, inclusive. Read SEC document |
| December 10, 2021 Filed Dec 13, 2021 21:19 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 3,600 | $68.67 | $247,212.00 |
DisclosureSEC source: 0001666071-21-000241 · wf-form4_163943034099412.xml · nonDerivative · entry 3 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,765 F3 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on December 9, 2021. F5 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $68.25 to $69.23, inclusive. Read SEC document |
| December 10, 2021 Filed Dec 13, 2021 21:19 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 2,166 | $67.64 | $146,508.24 |
DisclosureSEC source: 0001666071-21-000241 · wf-form4_163943034099412.xml · nonDerivative · entry 2 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,365 F3 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on December 9, 2021. F4 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $67.20 to $68.13, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4), (5) and (6) to this Form 4. Read SEC document |
| December 09, 2021 Filed Dec 13, 2021 21:19 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionPerformance Stock Unit · Derivative | 15,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-21-000241 · wf-form4_163943034099412.xml · derivative · entry 6 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,625 Underlying: Common Stock · 15,625 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. F7 · derivative.exercise_date: On December 9, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum growth rate in adjusted contribution was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted contribution growth target ("adjusted contribution growth tranche"). Fifty percent (50%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer. F7 · derivative.expiration_date: On December 9, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum growth rate in adjusted contribution was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted contribution growth target ("adjusted contribution growth tranche"). Fifty percent (50%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer. Read SEC document |
| December 09, 2021 Filed Dec 13, 2021 21:19 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GrantPerformance Stock Unit · Derivative | 31,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-21-000241 · wf-form4_163943034099412.xml · derivative · entry 5 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,250 Underlying: Common Stock · 31,250 shares Expires not disclosed F1 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. F7 · derivative.exercise_date: On December 9, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum growth rate in adjusted contribution was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted contribution growth target ("adjusted contribution growth tranche"). Fifty percent (50%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer. F7 · derivative.expiration_date: On December 9, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum growth rate in adjusted contribution was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted contribution growth target ("adjusted contribution growth tranche"). Fifty percent (50%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer. Read SEC document |
| December 09, 2021 Filed Dec 13, 2021 21:19 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 15,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-21-000241 · wf-form4_163943034099412.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,531 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · balance_after: Includes 67 shares of Common Stock acquired under the Issuer's Employee Stock Purchase Plan. Read SEC document |
| November 05, 2021 Filed Nov 8, 2021 22:24 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 5,070 | $92.95 | $471,256.50 |
DisclosureSEC source: 0001666071-21-000220 · wf-form4_163641025741815.xml · nonDerivative · entry 4 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,839 F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on October 6, 2021 and prior stock sales. F5 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $92.79 to $93.01, inclusive. Read SEC document |
| November 05, 2021 Filed Nov 8, 2021 22:24 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 300 | $91.55 | $27,465.00 |
DisclosureSEC source: 0001666071-21-000220 · wf-form4_163641025741815.xml · nonDerivative · entry 3 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,909 F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on October 6, 2021 and prior stock sales. F4 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $91.39 to $91.88, inclusive. Read SEC document |
| November 05, 2021 Filed Nov 8, 2021 22:24 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 3,100 | $90.40 | $280,240.00 |
DisclosureSEC source: 0001666071-21-000220 · wf-form4_163641025741815.xml · nonDerivative · entry 2 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,209 F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on October 6, 2021 and prior stock sales. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $90.35 to $90.66, inclusive. Read SEC document |
| November 05, 2021 Filed Nov 8, 2021 22:24 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 2,998 | $90.04 | $269,939.92 |
DisclosureSEC source: 0001666071-21-000220 · wf-form4_163641025741815.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,309 F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on October 6, 2021 and prior stock sales. F2 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $89.34 to $90.335, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2), (3), (4) and (5) to this Form 4. Read SEC document |
| October 06, 2021 Filed Oct 6, 2021 22:10 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionPerformance Stock Unit · Derivative | 15,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-21-000198 · wf-form4_163355823469057.xml · derivative · entry 3 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,625 Underlying: Common Stock · 15,625 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: On October 6, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum number of advertisers with a specified billings threshold over a trailing 12-month period was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the advertiser count target ("advertiser tranche"). Fifty percent (50%) of the shares subject to the advertiser tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU will vest 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer. F3 · derivative.expiration_date: On October 6, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum number of advertisers with a specified billings threshold over a trailing 12-month period was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the advertiser count target ("advertiser tranche"). Fifty percent (50%) of the shares subject to the advertiser tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU will vest 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer. Read SEC document |
| October 06, 2021 Filed Oct 6, 2021 22:10 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GrantPerformance Stock Unit · Derivative | 31,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-21-000198 · wf-form4_163355823469057.xml · derivative · entry 2 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,250 Underlying: Common Stock · 31,250 shares Expires not disclosed F2 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: On October 6, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum number of advertisers with a specified billings threshold over a trailing 12-month period was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the advertiser count target ("advertiser tranche"). Fifty percent (50%) of the shares subject to the advertiser tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU will vest 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer. F3 · derivative.expiration_date: On October 6, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum number of advertisers with a specified billings threshold over a trailing 12-month period was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the advertiser count target ("advertiser tranche"). Fifty percent (50%) of the shares subject to the advertiser tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU will vest 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer. Read SEC document |
| October 06, 2021 Filed Oct 6, 2021 22:10 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 15,625 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-21-000198 · wf-form4_163355823469057.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,307 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the underlying vested shares of common stock of the Issuer which have not been delivered. F2 · price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| August 30, 2021 Filed Aug 31, 2021 21:45 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 60 | $0.00 Strike: $30.44 | $0.00 |
DisclosureSEC source: 0001666071-21-000171 · wf-form4_163044633430353.xml · derivative · entry 2 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 60 shares Expires 2027-07-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| August 30, 2021 Filed Aug 31, 2021 21:45 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 60 | $30.44 | $1,826.40 |
DisclosureSEC source: 0001666071-21-000171 · wf-form4_163044633430353.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,682 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 19, 2021 Filed May 21, 2021 20:25 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,125 | $0.00 Strike: $30.44 | $0.00 |
DisclosureSEC source: 0001666071-21-000095 · wf-form4_162162871923684.xml · derivative · entry 2 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60 Underlying: Common Stock · 3,125 shares Expires 2027-07-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| May 19, 2021 Filed May 21, 2021 20:25 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 3,125 | $30.44 | $95,125.00 |
DisclosureSEC source: 0001666071-21-000095 · wf-form4_162162871923684.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,622 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 165 shares of Common Stock acquired under the Issuer's Employee Stock Purchase Plan. Read SEC document |
| May 10, 2021 Filed May 11, 2021 22:31 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 32 | $95.48 | $3,055.36 |
DisclosureSEC source: 0001666071-21-000087 · wf-form4_162077226751798.xml · nonDerivative · entry 4 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,332 F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for RSUs that vested on April 1, 2021. Read SEC document |
| May 10, 2021 Filed May 11, 2021 22:31 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 5,000 | $98.25 | $491,250.00 |
DisclosureSEC source: 0001666071-21-000087 · wf-form4_162077226751798.xml · nonDerivative · entry 3 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,364 F4 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. Read SEC document |
| May 07, 2021 Filed May 11, 2021 22:31 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 1,000 | $100.91 | $100,910.00 |
DisclosureSEC source: 0001666071-21-000087 · wf-form4_162077226751798.xml · nonDerivative · entry 2 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,364 F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for RSUs that vested on April 1, 2021. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $100.81 to $101.10, inclusive. Read SEC document |
| May 07, 2021 Filed May 11, 2021 22:31 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 1,544 | $100.29 | $154,847.76 |
DisclosureSEC source: 0001666071-21-000087 · wf-form4_162077226751798.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,364 F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for RSUs that vested on April 1, 2021. F2 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $99.81 to $100.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) and (3) to this Form 4. Read SEC document |
| April 12, 2021 Filed Apr 14, 2021 21:52 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 602 | $111.88 | $67,351.76 |
DisclosureSEC source: 0001666071-21-000069 · wf-form4_161843710683856.xml · nonDerivative · entry 4 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,908 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. F5 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $111.74 to $112.00, inclusive. Read SEC document |
| April 12, 2021 Filed Apr 14, 2021 21:52 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 3,383 | $111.11 | $375,885.13 |
DisclosureSEC source: 0001666071-21-000069 · wf-form4_161843710683856.xml · nonDerivative · entry 3 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,510 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. F4 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $110.645 to $111.64, inclusive. Read SEC document |
| April 12, 2021 Filed Apr 14, 2021 21:52 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 3,515 | $109.88 | $386,228.20 |
DisclosureSEC source: 0001666071-21-000069 · wf-form4_161843710683856.xml · nonDerivative · entry 2 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,893 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $109.55 to $110.54, inclusive. Read SEC document |
| April 12, 2021 Filed Apr 14, 2021 21:52 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 900 | $109.04 | $98,136.00 |
DisclosureSEC source: 0001666071-21-000069 · wf-form4_161843710683856.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,408 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. F2 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $108.52 to $109.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), and (5) to this Form 4. Read SEC document |
| April 05, 2021 Filed Apr 7, 2021 21:54 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GrantRestricted Stock Unit · Derivative | 6,818 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-21-000060 · wf-form4_161783244909071.xml · derivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,818 Underlying: Common Stock · 6,818 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F2 · derivative.exercise_date: The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date. F2 · derivative.expiration_date: The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date. Read SEC document |
| April 01, 2021 Filed Apr 6, 2021 00:10 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Unit · Derivative | 8,467 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-21-000046 · wf-form4_161766776316962.xml · derivative · entry 2 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,404 Underlying: Common Stock · 8,467 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F3 · derivative.exercise_date: The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date. F3 · derivative.expiration_date: The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date. Read SEC document |
| April 01, 2021 Filed Apr 6, 2021 00:10 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 8,467 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-21-000046 · wf-form4_161766776316962.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,308 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the underlying vested shares of common stock of the Issuer which have not been delivered. F2 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 21:19 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 100 | $131.98 | $13,198.00 |
DisclosureSEC source: 0001666071-21-000036 · wf-form4_161558394308757.xml · nonDerivative · entry 7 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,309 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 21:19 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 600 | $131.39 | $78,834.00 |
DisclosureSEC source: 0001666071-21-000036 · wf-form4_161558394308757.xml · nonDerivative · entry 6 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,409 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. F7 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $130.96 to $131.72, inclusive. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.